Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

18 Apr 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated April 18, 2022 titled ‘Zydus Lifesciences receives final approval from USFDA for Cyanocobalamin Injection’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1906.55
Dr. Reddys Labs. 1380.20
Cipla 1403.95
Lupin 2007.00
Zydus Lifesciences 1212.45
View more..